Showing results (51-60 of 171) with videos related to

Sort By:
Pageof 18
Clinical Lung Cancer|June 30, 2023
Pembrolizumab Alone or With Chemotherapy for 70+ Year-Old Lung Cancer Patients: A Retrospective StudyMiriam Blasi, Jonas Kuon, Rajiv Shah, et al.
Case Reports in Oncology|May 12, 2021
Combination of Crizotinib and Osimertinib in T790M+ EGFR-Mutant Non-Small Cell Lung Cancer with Emerging MET Amplification Post-Osimertinib Progression in a 10-Year Survivor: A Case ReportMiriam Blasi, Daniel Kazdal, Michael Thomas, et al.
Lung Cancer (Amsterdam, Netherlands)|February 4, 2025
Proposal of real-world solutions for the implementation of predictive biomarker testing in patients with operable non-small cell lung cancerPaul Hofman, Petros Christopoulos, Nicky D'Haene, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 4, 2023
Distribution and Detectability of EGFR Exon 20 Insertion Variants in NSCLCSai-Hong Ignatius Ou, Jin-Liern Hong, Petros Christopoulos, et al.
Clinical Epigenetics|December 2, 2022
Longitudinal monitoring of cell-free DNA methylation in ALK-positive non-small cell lung cancer patientsFlorian Janke, Arlou Kristina Angeles, Anja Lisa Riediger, et al.
BMC Medical Imaging|December 5, 2022
Dynamic contrast enhanced MRI of pulmonary adenocarcinomas for early risk stratification: higher contrast uptake associated with response and better prognosisStephan Rheinheimer, Petros Christopoulos, Stella Erdmann, et al.
Clinical Lung Cancer|July 17, 2023
Prognostic Impact of the Immune-Cell Infiltrate in N1-Positive Non-Small-Cell Lung CancerFlorian Eichhorn, Andreas Weigert, Rajender Nandigama, et al.
Lung Cancer (Amsterdam, Netherlands)|March 7, 2020
Quantifying potential confounders of panel-based tumor mutational burden (TMB) measurementJan Budczies, Daniel Kazdal, Michael Allgäuer, et al.
International Journal of Oncology|January 20, 2017
AURKA, DLGAP5, TPX2, KIF11 and CKAP5: Five specific mitosis-associated genes correlate with poor prognosis for non-small cell lung cancer patientsMarc A Schneider, Petros Christopoulos, Thomas Muley, et al.
Data in Brief|December 28, 2020
Durvalumab after definitive chemoradiotherapy in locally advanced NSCLC: Data of the German EAPMartin Faehling, Christian Schumann, Petros Christopoulos, et al.
Pageof 18